Drug Shortage Report for TEVA-DEXTROAMPHETAMINE SR
Report ID | 184225 |
Drug Identification Number | 02448327 |
Brand name | ACT DEXTROAMPHETAMINE SR |
Common or Proper name | DEXTROAMPHETAMINE SRCAP 15MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROAMPHETAMINE SULFATE |
Strength(s) | 15MG |
Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-02-07 |
Estimated end date | 2023-05-20 |
Actual end date | 2023-06-08 |
Shortage status | Resolved |
Updated date | 2023-06-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-02-09 | English | Compare |
v2 | 2023-02-09 | French | Compare |
v3 | 2023-04-27 | English | Compare |
v4 | 2023-04-27 | French | Compare |
v5 | 2023-06-08 | English | Compare |
v6 | 2023-06-08 | French | Compare |
v7 | 2023-06-09 | English | Compare |
Showing 1 to 7 of 7